Novo Holdings A/S Long-Term Concentrated

CIK: 0001388325 · Show all filings

Period: Q3 2024 (← Previous) (Next →)

Filing Date: Oct 24, 2024

Total Value ($000): $2,013,443 (100.0% shares, 0.0% debt)

Holdings (37)

VTI VANGUARD INDEX FDS 14.6%
Value ($000) $294,076 Shares 1,038,550 Est. Cost $267.51 Unrealized
TEM TEMPUS AI INC 11.5%
Value ($000) $230,612 Shares 4,074,419 Est. Cost $30.66 Unrealized +52.5%
BN BROOKFIELD CORP 9.2%
Value ($000) $185,559 Shares 3,491,230 Est. Cost $22.16 Unrealized +41.2%
EWTX EDGEWISE THERAPEUTICS INC 7.4%
Value ($000) $148,127 Shares 5,549,900 Est. Cost $17.44 Unrealized +14.1%
CORT CORCEPT THERAPEUTICS INC 5.5%
Value ($000) $111,598 Shares 2,411,362 Est. Cost $23.02 Unrealized +54.4%
ASML ASML HOLDING N V 5.5%
Value ($000) $111,102 Shares 133,336 Est. Cost $654.82 Unrealized
CRM SALESFORCE INC 5.0%
Value ($000) $100,879 Shares 368,560 Est. Cost $193.03 Unrealized +31.5%
PCVX VAXCYTE INC 4.3%
Value ($000) $85,703 Shares 750,000 Est. Cost $31.07 Unrealized +190.1%
MIRM MIRUM PHARMACEUTICALS INC 2.9%
Value ($000) $58,500 Shares 1,500,000 Est. Cost $12.27 Unrealized +225.2%
VRDN VIRIDIAN THERAPEUTICS INC 2.7%
Value ($000) $54,259 Shares 2,385,000 Est. Cost $16.80 Unrealized -2.7%
BABA ALIBABA GROUP HLDG LTD 2.6%
Value ($000) $53,148 Shares 500,827 Est. Cost $165.09 Unrealized
INSM INSMED INC 2.6%
Value ($000) $52,901 Shares 724,666 Est. Cost $23.10 Unrealized +219.4%
CRNX CRINETICS PHARMACEUTICALS IN 2.5%
Value ($000) $51,100 Shares 1,000,000 Est. Cost $19.36 Unrealized +166.3%
CABO CABLE ONE INC 2.1%
Value ($000) $41,416 Shares 118,403 Est. Cost $987.67 Unrealized -64.6%
AVBP ARRIVENT BIOPHARMA INC 1.8%
Value ($000) $35,375 Shares 1,505,315 Est. Cost $19.51 Unrealized +16.3%
MERUS N V 1.7%
Value ($000) $34,972 Shares 700,000 Est. Cost $58.84 Unrealized
BMRN BIOMARIN PHARMACEUTICAL INC 1.7%
Value ($000) $34,442 Shares 490,000 Est. Cost $84.22 Unrealized -0.8%
CLDX CELLDEX THERAPEUTICS INC NEW 1.6%
Value ($000) $32,755 Shares 963,663 Est. Cost $37.78 Unrealized +0.9%
ALNY ALNYLAM PHARMACEUTICALS INC 1.6%
Value ($000) $32,559 Shares 118,383 Est. Cost $160.04 Unrealized +62.7%
PHVS PHARVARIS N V 1.6%
Value ($000) $31,947 Shares 1,725,000 Est. Cost $15.26 Unrealized +19.7%
LANZATECH GLOBAL INC 1.5%
Value ($000) $30,206 Shares 15,814,845 Est. Cost $3.88 Unrealized
BAM BROOKFIELD ASSET MANAGMT LTD 1.5%
Value ($000) $29,661 Shares 627,207 Est. Cost $31.11 Unrealized +28.9%
CARGO THERAPEUTICS INC 1.4%
Value ($000) $28,487 Shares 1,544,000 Est. Cost $21.87 Unrealized
FOLD AMICUS THERAPEUTICS INC 1.3%
Value ($000) $26,700 Shares 2,500,000 Est. Cost $12.83 Unrealized -15.1%
RCKT ROCKET PHARMACEUTICALS INC 1.0%
Value ($000) $20,317 Shares 1,100,000 Est. Cost $28.09 Unrealized -27.1%
ZBIO ZENAS BIOPHARMA INC 1.0%
Value ($000) $19,458 Shares 1,150,000 Est. Cost $17.98 Unrealized 0.0%
FDMT 4D MOLECULAR THERAPEUTICS IN 0.8%
Value ($000) $16,215 Shares 1,500,000 Est. Cost $17.55 Unrealized -5.4%
BLUEPRINT MEDICINES CORP 0.8%
Value ($000) $16,188 Shares 175,000 Est. Cost $59.75 Unrealized
VERVE THERAPEUTICS INC 0.6%
Value ($000) $11,616 Shares 2,400,000 Est. Cost $12.43 Unrealized
LXEO LEXEO THERAPEUTICS INC 0.5%
Value ($000) $10,148 Shares 1,122,581 Est. Cost $13.07 Unrealized -8.8%
KYTX KYVERNA THERAPEUTICS INC 0.4%
Value ($000) $9,047 Shares 1,850,000 Est. Cost $19.62 Unrealized -60.7%
MGX METAGENOMI INC 0.2%
Value ($000) $3,906 Shares 1,800,000 Est. Cost $11.34 Unrealized -69.4%
IOBT IO BIOTECH INC 0.2%
Value ($000) $3,522 Shares 3,354,449 Est. Cost $6.26 Unrealized -79.9%
ABCL ABCELLERA BIOLOGICS INC 0.1%
Value ($000) $2,930 Shares 1,126,915 Est. Cost $8.47 Unrealized -67.3%
MQ MARQETA INC 0.1%
Value ($000) $2,172 Shares 441,558 Est. Cost $22.37 Unrealized -76.6%
GLTO GALECTO INC 0.1%
Value ($000) $1,214 Shares 99,913 Est. Cost $13.05 Unrealized 0.0%
SPRO SPERO THERAPEUTICS INC 0.0%
Value ($000) $628 Shares 468,902 Est. Cost $11.41 Unrealized -88.3%